Ginkgo Bioworks Announces Date of Third Quarter 2025 Results Presentation
Rhea-AI Summary
Ginkgo Bioworks (NYSE: DNA) will host a third-quarter 2025 results presentation and live Q&A on Thursday, November 6, 2025 beginning at 4:30 p.m. ET. The presentation will review business performance for the quarter ended September 30, 2025.
Webcast details and the replay will be available on Ginkgo's investor relations website at https://investors.ginkgobioworks.com. Investors can submit questions in advance via X using hashtag #GinkgoResults or by emailing investors@ginkgobioworks.com.
Positive
- None.
Negative
- None.
News Market Reaction
On the day this news was published, DNA declined 1.48%, reflecting a mild negative market reaction. Argus tracked a peak move of +5.4% during that session. Our momentum scanner triggered 21 alerts that day, indicating elevated trading interest and price volatility. This price movement removed approximately $12M from the company's valuation, bringing the market cap to $780M at that time.
Data tracked by StockTitan Argus on the day of publication.
Presentation and Q&A session scheduled for post-market on Thursday, November 6, 2025
The presentation details and webcast link will be available on Ginkgo's investor relations website at https://investors.ginkgobioworks.com, and a replay will be made available.
To ask a question ahead of the presentation, please submit them to @Ginkgo on X (hashtag #GinkgoResults) or by sending an e-mail to investors@ginkgobioworks.com.
About Ginkgo Bioworks
Ginkgo Bioworks builds the tools that make biology easier to engineer for everyone. Ginkgo R&D Solutions delivers customizable R&D packages—such as protein engineering, nucleic acid design, and cell-free systems—giving partners a comprehensive way to accelerate innovation across therapeutics, diagnostics, & manufacturing. Ginkgo Automation sells modular, integrated laboratory automation so scientists can spend their days planning and analyzing experiments rather than pipetting in the lab. Ginkgo Datapoints uses Ginkgo's in-house automation to generate the large lab data sets to power your AI models. Ginkgo Biosecurity is building and deploying the next-generation infrastructure and technologies that global leaders need to predict, detect, and respond to a wide variety of biological threats. For more information, visit ginkgobioworks.com and ginkgobiosecurity.com, read our blog, or follow us on social media channels such as X (@Ginkgo and @Ginkgo_Biosec), Instagram (@GinkgoBioworks), Threads (@GinkgoBioworks), or LinkedIn.
Ginkgo Bioworks Contacts:
INVESTOR CONTACT:
MEDIA CONTACT:
View original content to download multimedia:https://www.prnewswire.com/news-releases/ginkgo-bioworks-announces-date-of-third-quarter-2025-results-presentation-302600232.html
SOURCE Ginkgo Bioworks
FAQ
When will Ginkgo Bioworks (DNA) present its third-quarter 2025 results?
How can I access the Ginkgo Bioworks (DNA) Q3 2025 webcast and replay?
How can investors submit questions for Ginkgo Bioworks (DNA) ahead of the November 6, 2025 presentation?
What period will Ginkgo Bioworks (DNA) cover in the November 6, 2025 presentation?
Will there be a replay available for the Ginkgo Bioworks (DNA) Q3 2025 presentation?
Is the Ginkgo Bioworks (DNA) Q3 2025 session a live Q&A as well as a presentation?
